High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice isindependent of changes in amyloid and tau pathology

Neurobiology of Aging

Volumn 35, Issue 8, 2014, Pages 1821-1832

  Knight, Elysse M ^a   Martins, Isaura V A ^a   Gümüsgöz, Sarah ^a   Allan, Stuart M ^a   Lawrence, Catherine B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

3xTgAD; Adipose tissue; High fat diet; Memory; Metabolism; Obesity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EPIDIDYMIS FAT; FAT INTAKE; FATTY ACID SYNTHESIS; IMMUNOHISTOCHEMISTRY; LIPID DIET; MALE; MEMORY DISORDER; MOUSE; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT TERM MEMORY; SPATIAL MEMORY; TISSUE PREPARATION; ADIPOSE TISSUE; ANIMAL; BRAIN; COGNITION; DISEASE MODEL; EPIDIDYMIS; MEMORY; METABOLISM; PATHOLOGY; PSYCHOLOGY; RISK; TRANSGENIC MOUSE;

ADIPOSE TISSUE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; COGNITION; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EPIDIDYMIS; MALE; MEMORY; MICE; MICE, TRANSGENIC; RISK; TAU PROTEINS;

EID: 84899898904     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.02.010     Document Type: Article

References (56)

1. Adebakin A., Bradley J., Gumusgoz S., Waters E.J., Lawrence C.B. Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model. PLoS. One 2012, 7:e45179.
2. Beydoun M.A., Beydoun H.A., Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes. Rev. 2008, 9:204-218.
3. Billings L.M., Oddo S., Green K.N., McGaugh J.L., Laferla F.M. Intraneuronal abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
4. Buchman A.S., Wilson R.S., Bienias J.L., Shah R.C., Evans D.A., Bennett D.A. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005, 65:892-897.
5. Drake C., Boutin H., Jones M.S., Denes A., McColl B.W., Selvarajah J.R., Hulme S., Georgiou R.F., Hinz R., Gerhard A., Vail A., Prenant C., Julyan P., Maroy R., Brown G., Smigova A., Herholz K., Kassiou M., Crossman D., Francis S., Proctor S.D., Russell J.C., Hopkins S.J., Tyrrell P.J., Rothwell N.J., Allan S.M. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav. Immun. 2011, 25:1113-1122.
6. Eskelinen M.H., Ngandu T., Helkala E.L., Tuomilehto J., Nissinen A., Soininen H., Kivipelto M. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int. J. Geriatr. Psychiatry 2008, 23:741-747.
7. Fitzpatrick A.L., Kuller L.H., Lopez O.L., Diehr P., O'Meara E.S., Longstreth W.T., Luchsinger J.A. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch. Neurol. 2009, 66:336-342.
8. Gazdzinski S., Kornak J., Weiner M.W., Meyerhoff D.J. Body mass index and magnetic resonance markers of brain integrity in adults. Ann. Neurol. 2008, 63:652-657.
9. Grant W.B. Dietary links to Alzheimer's disease. Alzheimer's Dis. Rev. 1997, 2:42-45.
10. Grant W.B. Dietary links to Alzheimer's disease: 1999 update. J.Alzheimers Dis. 1999, 1:197-201.
11. Gustafson D., Lissner L., Bengtsson C., Bjorkelund C., Skoog I. A24-year follow-up of body mass index and cerebral atrophy. Neurology 2004, 63:1876-1881.
12. Gustafson D., Rothenberg E., Blennow K., Steen B., Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch. Intern. Med. 2003, 163:1524-1528.
13. Gustafson D.R., Steen B., Skoog I. Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. Int. Psychogeriatr. 2004, 16:327-336.
14. Halagappa V.K., Guo Z., Pearson M., Matsuoka Y., Cutler R.G., Laferla F.M., Mattson M.P. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2007, 26:212-220.
15. Hassing L.B., Dahl A.K., Thorvaldsson V., Berg S., Gatz M., Pedersen N.L., Johansson B. Overweight in midlife and risk of dementia: a 40-year follow-up study. Int. J. Obes. (Lond) 2009, 33:893-898.
16. Herculano B., Tamura M., Ohba A., Shimatani M., Kutsuna N., Hisatsune T. β-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer's disease. J.Alzheimers Dis. 2013, 33:983-997.
17. Hiramatsu M., Sasaki M., Nabeshima T., Kameyama T. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol. Biochem. Behav. 1997, 56:73-79.
18. Ho L., Qin W., Pompl P.N., Xiang Z., Wang J., Zhao Z., Peng Y., Cambareri G., Rocher A., Mobbs C.V., Hof P.R., Pasinetti G.M. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J. 2004, 18:902-904.
19. Jagust W., Harvey D., Mungas D., Haan M. Central obesity and the aging brain. Arch. Neurol. 2005, 62:1545-1548.
20. Jeong S.K., Nam H.S., Son M.H., Son E.J., Cho K.H. Interactive effect of obesity indexes on cognition. Dement. Geriatr. Cogn. Disord. 2005, 19:91-96.
21. Johnston H., Boutin H., Allan S.M. Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem. Soc. Trans. 2011, 39:886-890.
22. Julien C., Tremblay C., Phivilay A., Berthiaume L., Emond V., Julien P., Calon F. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol. Aging 2010, 31:1516-1531.
23. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 1997, 42:776-782.
24. Kanoski S.E., Davidson T.L. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol. Behav. 2011, 103:59-68.
25. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kareholt I., Winblad B., Helkala E.L., Tuomilehto J., Soininen H., Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 2005, 62:1556-1560.
26. Knight E.M., Brown T.M., Gumusgoz S., Smith J.C., Waters E.J., Allan S.M., Lawrence C.B. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice. Dis. Model Mech. 2013, 6:160-170.
27. Knight E.M., Verkhratsky A., Luckman S.M., Allan S.M., Lawrence C.B. Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 2012, 33:187-193.
28. Laitinen M.H., Ngandu T., Rovio S., Helkala E.L., Uusitalo U., Viitanen M., Nissinen A., Tuomilehto J., Soininen H., Kivipelto M. Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement. Geriatr. Cogn. Disord. 2006, 22:99-107.
29. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., Ashe K.H. Aspecific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
30. Luchsinger J.A., Tang M.X., Shea S., Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 2002, 59:1258-1263.
31. Maesako M., Uemura K., Kubota M., Kuzuya A., Sasaki K., Asada M., Watanabe K., Hayashida N., Ihara M., Ito H., Shimohama S., Kihara T., Kinoshita A. Environmental enrichment ameliorated high-fat diet-induced Abeta deposition and memory deficit in APP transgenic mice. Neurobiol. Aging 2012, 33:1011-1023.
32. Maesako M., Uemura K., Kubota M., Kuzuya A., Sasaki K., Hayashida N., sada-Utsugi M., Watanabe K., Uemura M., Kihara T., Takahashi R., Shimohama S., Kinoshita A. Exercise is more effective than diet control in preventing high fat diet-induced beta-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J.Biol. Chem. 2012, 287:23024-23033.
33. McNeilly A.D., Williamson R., Sutherland C., Balfour D.J., Stewart C.A. High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behav. Brain Res. 2011, 217:134-141.
34. Oddo S., Caccamo A., Kitazawa M., Tseng B.P., Laferla F.M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging 2003, 24:1063-1070.
35. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., Laferla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
36. Panza F., Solfrizzi V., Colacicco A.M., D'Introno A., Capurso C., Torres F., Del Parigi A., Capurso S., Capurso A. Mediterranean diet and cognitive decline. Public Health Nutr. 2004, 7:959-963.
37. Paxinos G., Franklin K. The Mouse Brain in Stereotaxic Coordintes 2001, Academic Press, London, UK.
38. Pedrini S., Thomas C., Brautigam H., Schmeidler J., Ho L., Fraser P., Westaway D., Hyslop P.S., Martins R.N., Buxbaum J.D., Pasinetti G.M., Dickstein D.L., Hof P.R., Ehrlich M.E., Gandy S. Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology. Mol. Neurodegener. 2009, 4:40.
39. Phivilay A., Julien C., Tremblay C., Berthiaume L., Julien P., Giguere Y., Calon F. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Neuroscience 2009, 159:296-307.
40. Pistell P.J., Morrison C.D., Gupta S., Knight A.G., Keller J.N., Ingram D.K., Bruce-Keller A.J. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J.Neuroimmunol. 2010, 219:25-32.
41. Profenno L.A., Porsteinsson A.P., Faraone S.V. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol. Psychiatry 2010, 67:505-512.
42. Rosengren A., Skoog I., Gustafson D., Wilhelmsen L. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch. Intern. Med. 2005, 165:321-326.
43. Serrano-Pozo A., Frosch M.P., Masliah E., Hyman B.T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2011, 1:a006189.
44. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14:837-842.
45. Stewart R., Masaki K., Xue Q.L., Peila R., Petrovitch H., White L.R., Launer L.J. A32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch. Neurol. 2005, 62:55-60.
46. Takeda S., Sato N., Uchio-Yamada K., Sawada K., Kunieda T., Takeuchi D., Kurinami H., Shinohara M., Rakugi H., Morishita R. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. U.S.A 2010, 107:7036-7041.
47. Verri M., Pastoris O., Dossena M., Aquilani R., Guerriero F., Cuzzoni G., Venturini L., Ricevuti G., Bongiorno A.I. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease. Int. J. Immunopathol. Pharmacol. 2012, 25:345-353.
48. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 2006, 1:848-858.
49. Wall P.M., Messier C. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory. Psychopharmacology (Berl) 2002, 160:233-244.
50. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation invivo. Nature 2002, 416:535-539.
51. Ward M.A., Carlsson C.M., Trivedi M.A., Sager M.A., Johnson S.C. The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol. 2005, 5:23.
52. Whitmer R.A., Gunderson E.P., Barrett-Connor E., Quesenberry C.P., Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005, 330:1360.
53. Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res. 2007, 4:103-109.
54. Whitmer R.A., Gustafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008, 71:1057-1064.
55. Winocur G., Greenwood C.E. Studies of the effects of high fat dietsoncognitive function in a rat model. Neurobiol. Aging 2005, 26(Suppl. 1):46-49.
56. Wyss-Coray T., Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med. 2012, 2:a006346.